| Challenges and future prospects for the delivery of biologics: oral mucosal, pulmonary, and transdermal routes JO Morales, KR Fathe, A Brunaugh, S Ferrati, S Li, M Montenegro-Nicolini, ... The AAPS journal 19, 652-668, 2017 | 143 | 2017 |
| Mitotic trafficking of silicon microparticles RE Serda, S Ferrati, B Godin, E Tasciotti, XW Liu, M Ferrari Nanoscale 1 (2), 250-259, 2009 | 114 | 2009 |
| Logic‐Embedded Vectors for Intracellular Partitioning, Endosomal Escape, and Exocytosis of Nanoparticles RE Serda, A Mack, AL Van De Ven, S Ferrati, K Dunner Jr, B Godin, ... Small 6 (23), 2691-2700, 2010 | 111 | 2010 |
| Leveraging nanochannels for universal, zero-order drug delivery in vivo S Ferrati, D Fine, J You, E De Rosa, L Hudson, E Zabre, S Hosali, ... Journal of controlled release 172 (3), 1011-1019, 2013 | 83 | 2013 |
| Intracellular trafficking of silicon particles and logic-embedded vectors S Ferrati, A Mack, C Chiappini, X Liu, AJ Bean, M Ferrari, RE Serda Nanoscale 2 (8), 1512-1520, 2010 | 78 | 2010 |
| Multistage delivery of chemotherapeutic nanoparticles for breast cancer treatment E Blanco, T Sangai, A Hsiao, S Ferrati, L Bai, X Liu, F Meric-Bernstam, ... Cancer letters 334 (2), 245-252, 2013 | 76 | 2013 |
| Characterization of a nanogland for the autotransplantation of human pancreatic islets OM Sabek, S Ferrati, DW Fraga, J Sih, EV Zabre, DH Fine, M Ferrari, ... Lab on a chip 13 (18), 3675-3688, 2013 | 61 | 2013 |
| Sustained zero‐order release of intact ultra‐stable drug‐loaded liposomes from an implantable nanochannel delivery system C Celia, S Ferrati, S Bansal, AL van de Ven, B Ruozi, E Zabre, S Hosali, ... Advanced healthcare materials 3 (2), 230-238, 2014 | 60 | 2014 |
| Excipient-free pulmonary delivery and macrophage targeting of clofazimine via air jet micronization AD Brunaugh, SU Jan, S Ferrati, HDC Smyth Molecular pharmaceutics 14 (11), 4019-4031, 2017 | 45 | 2017 |
| Connectosomes for direct molecular delivery to the cellular cytoplasm AK Gadok, DJ Busch, S Ferrati, B Li, HDC Smyth, JC Stachowiak Journal of the American Chemical Society 138 (39), 12833-12840, 2016 | 43 | 2016 |
| Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health J Sih, SS Bansal, S Filipini, S Ferrati, K Raghuwansi, E Zabre, E Nicolov, ... Analytical and bioanalytical chemistry 405, 1547-1557, 2013 | 38 | 2013 |
| The nanochannel delivery system for constant testosterone replacement therapy S Ferrati, E Nicolov, E Zabre, T Geninatti, BA Shirkey, L Hudson, S Hosali, ... The Journal of Sexual Medicine 12 (6), 1375-1380, 2015 | 37 | 2015 |
| Docetaxel/2-hydroxypropyl β-cyclodextrin inclusion complex increases docetaxel solubility and release from a nanochannel drug delivery system S Ferrati, E Nicolov, S Bansal, S Hosali, M Landis, A Grattoni Current drug targets 16 (14), 1645-1649, 2015 | 34 | 2015 |
| Multistage mesoporous silicon-based nanocarriers: biocompatibility with immune cells and controlled degradation in physiological fluids B Godin, J Gu, RE Serda, S Ferrati, X Liu, C Chiappini, T Tanaka, ... Controlled release newsletter/Controlled Release Society 25 (4), 9, 2008 | 32 | 2008 |
| Influence of formulation factors on the aerosol performance and stability of lysozyme powders: a systematic approach S Ferrati, T Wu, O Fuentes, AD Brunaugh, SR Kanapuram, HDC Smyth AAPS PharmSciTech 19, 2755-2766, 2018 | 26 | 2018 |
| Inter‐endothelial transport of microvectors using cellular shuttles and tunneling nanotubes S Ferrati, S Shamsudeen, HD Summers, P Rees, JVA Abbey, J Schmulen, ... Small 8 (20), 3151-3160, 2012 | 26 | 2012 |
| Dosing considerations for inhaled biologics S Ferrati, T Wu, SR Kanapuram, HDC Smyth International journal of pharmaceutics 549 (1-2), 58-66, 2018 | 25 | 2018 |
| Analysis of a nanochanneled membrane structure through convective gas flow A Grattoni, E De Rosa, S Ferrati, Z Wang, A Gianesini, X Liu, F Hussain, ... Journal of Micromechanics and Microengineering 19 (11), 115018, 2009 | 23 | 2009 |
| Delivering enhanced testosterone replacement therapy through nanochannels S Ferrati, E Nicolov, S Bansal, E Zabre, T Geninatti, A Ziemys, L Hudson, ... Advanced healthcare materials 4 (3), 446-451, 2015 | 22 | 2015 |
| Inhaled biologics: from preclinical to product approval K Fathe, S Ferrati, D Moraga-Espinoza, A Yazdi, H DC Smyth Current pharmaceutical design 22 (17), 2501-2521, 2016 | 20 | 2016 |
